8-K
filed December 30, 2025, 6:59 PM ET
ticker PMI
CIK 0002030617
debt
confidence high
sentiment positive
materiality 0.75
Picard Medical secures up to $50M senior secured notes; initial $15M funded at 0% interest, with warrants
Picard Medical, Inc.
- Issued $15M initial senior secured notes due Dec 26, 2028, at 0% annual interest, with option for up to $35M additional.
- Warrants to purchase 7,009,346 shares at $2.675 per share, exercisable after 6-month lock-up or stockholder approval.
- Net proceeds to be used for working capital and general corporate purposes; WestPark Capital acted as placement agent.
- Notes are senior secured, collateralized by substantially all assets of Picard and IP of SynCardia subsidiary.
- Company must maintain $4M cash minimum, seek stockholder approval for share issuance and authorized share increase to 300M.
Key facts
Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
Picard Medical, Inc. incurred senior notes of $15,000,000 at 0.00% maturing December 26, 2028.
- Instrument
- senior notes
- Principal
- $15,000,000
- Rate
- 0.00%
- Maturity
- December 26, 2028
- Event
- incurrence
Exact text from the filing
On December 26, 2025 (the “Initial Closing”), the Company, pursuant to the Purchase Agreement, issued the Initial Purchased Notes (as defined in the Purchase Agreement) in an aggregate principal amount of $15,000,000, as the first draw under a notes facility.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Picard Medical, Inc. entered into Security Agreement (effective 2025-12-26).
- Action
- entry
- Effective
- 2025-12-26
Exact text from the filing
In connection with the Purchase Agreement and the issuance of the Notes, (i) the Company entered into a Security Agreement, dated as of the Initial Closing (the “Security Agreement”), pursuant to which the Company granted a first-priority security interest in substantially all of the tangible and intangible assets of the Company and certain of its US subsidiaries, subject to permitted liens and exceptions, to secure the Company’s Obligations (as defined in the Security Agreement) under the Note Documents (as defined in the Security Agreement) and related transaction documents
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Picard Medical, Inc. entered into engagement letter with WestPark Capital, Inc..
- Action
- entry
- Agreement
- underwriting
- Counterparty
- WestPark Capital, Inc.
Exact text from the filing
In connection with the Private Placement, the Company entered into an engagement letter with WestPark Capital, Inc. (“WestPark”), pursuant to which WestPark acted as the Company’s exclusive placement agent.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Picard Medical, Inc. entered into Purchase Agreement with a single institutional investor (effective 2025-12-24).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- a single institutional investor
- Effective
- 2025-12-24
Exact text from the filing
On December 24, 2025, Picard Medical, Inc. (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with a single institutional investor (the “Buyer”), pursuant to which the Company agreed to issue and sell, in a private placement exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506(b) of Regulation D, promulgated thereunder (the “Private Placement”): (i) senior secured notes of the Company due December 26, 2028 (the “Notes”) and (ii) warrants (the “Warrants” and together with the Notes, the “Securities”) to purchase 7,009,346 shares of the Company’s common stock
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Picard Medical, Inc. entered into Notes with a single institutional investor valued at an aggregate principal amount of $15,000,000 (effective 2025-12-26).
- Action
- entry
- Agreement
- credit facility
- Counterparty
- a single institutional investor
- Value
- an aggregate principal amount of $15,000,000
- Effective
- 2025-12-26
Exact text from the filing
On December 26, 2025 (the “Initial Closing”), the Company, pursuant to the Purchase Agreement, issued the Initial Purchased Notes (as defined in the Purchase Agreement) in an aggregate principal amount of $15,000,000, as the first draw under a notes facility.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.